866-997-4948(US-Canada Toll Free)

Chronic Myelocytic Leukemia(CML) Global Clinical Trial Review, Q4, 2010

Published By :

GlobalData

Published Date : Oct 2010

Category :

Therapeutic Area

No. of Pages : 57 Pages


GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010"" provides data on the Chronic Myelocytic Leukemia (CML) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Chronic Myelocytic Leukemia (CML). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Chronic Myelocytic Leukemia (CML)). 

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

1 Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6

2 Introduction 7
2.1 Chronic Myelocytic Leukemia 7
2.2 Report Guidance 7

3 Clinical Trials by Region 8
3.1 Clinical Trials by Country 9
3.1.1 Top Countries Contributing to Clinical Trials in Asia-Pacific 11
3.1.2 Top Five Countries Contributing to Clinical Trials in Europe 12
3.1.3 Top Countries Contributing to Clinical Trials in North America 13
3.1.4 Top Countries Contributing to Clinical Trials in Central and South America 14
3.1.5 Top Countries Contributing to Clinical Trials in Middle East and Africa 15
3.2 Clinical Trials by BRIC Countries 16

4 Clinical Trials by Phase 17
4.1 In Progress Trials by Phase 18

5 Clinical Trials by Trial Status 19
5.1 Unaccomplished Trials of CML 21

6 Subjects Recruited Over a Period of Time 23
6.1 Enrollment Trends by Phase for the Last Decade 24

7 Prominent Sponsors 25
7.1 Top 10 Companies Participating in CNS Tumors Clinical Trials 26

8 Prominant Drug Comparison 28

9 Clinical Trial Profiles 29

9.1 Clinical Trial Overview of Top Companies 29
9.1.1 Novartis Pharmaceuticals Corporation 29
9.1.2 Bristol-Myers Squibb Company 31
9.1.3 ChemGenex Pharmaceuticals Limited 32
9.1.4 Pfizer Inc. 33
9.1.5 Astex Therapeutics Limited 33
9.1.6 AstraZeneca PLC 34
9.1.7 Celgene Corporation 34
9.1.8 SuperGen, Inc. 35
9.1.9 Natco Pharma Limited 35
9.1.10 Athersys, Inc. 35
9.1.11 Bio-Path Holdings, Inc. 36
9.1.12 Takeda Pharmaceutical Company Limited 36
9.1.13 Erimos Pharmaceuticals, LLC 36
9.1.14 Abbott Laboratories 37
9.1.15 Sunesis Pharmaceuticals, Inc. 37
9.1.16 Chiron Corporation 37
9.2 Clinical Trial Overview of Top Institutes / Hospitals / Universities 38
9.2.1 National Cancer Institute (NCI) 38
9.2.2 The University of Texas M. D. Anderson Cancer Center 40
9.2.3 Fred Hutchinson Cancer Research Center-Technology Transfer 42
9.2.4 University of Pennsylvania 43
9.2.5 St. Jude Childrens Research Hospital, Inc. 44
9.2.6 Sidney Kimmel Comprehensive Cancer Center 45
9.2.7 National Heart, Lung, and Blood Institute 46
9.2.8 Memorial Sloan Kettering Cancer Center 47
9.2.9 University of Bologna 48
9.2.10 European Organization for Research and Treatment of Cancer 48
9.2.11 IU Simon Cancer Center 49
9.2.12 University of Leeds 49
9.2.13 Howard Gurney 49
9.2.14 University of Maryland Marlene and Stewart Greenebaum Cancer Center 50
9.2.15 Medical College of Wisconsin 50
9.2.16 Robert H. Lurie Comprehensive Cancer Center of Northwestern University 51
9.2.17 Yale Cancer Center 51
9.2.18 Hadassah Medical Organization 52
9.2.19 HOVON 52
9.2.20 Indiana University School of Medicine 53

10 Appendix 54
10.1 Abbreviations 54
10.2 Definitions 54
10.3 Research Methodology 55
10.4 Secondary Research 56
10.5 About GlobalData 56
10.6 Contact Us 56
10.7 Disclaimer 57
10.8 Source 57

List of Table


Table 1: CML Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Table 2: CML Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 2010*
Table 3: CML Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2010*
Table 4: CML Therapeutics Clinical Trials, Europe, Top Five Countries, 2010*
Table 5: CML Therapeutics Clinical Trials, North America, Top Countries, 2010*
Table 6: CML Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010*
Table 7: CML Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010*
Table 8: CML Therapeutics Clinical Trials, BRIC Countries (%), 2010*
Table 9: CML Therapeutics Market, Global, Clinical Trials by Phase (%), 2010*
Table 10: CML Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010*
Table 11: CML Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Table 12: CML Therapeutics Market, Global, Suspended Clinical Trials, 2010*
Table 13: CML Therapeutics Market, Global, Withdrawn Clinical Trials, 2010*
Table 14: CML Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Table 15: CML Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009
Table 16: CML Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010*
Table 17: CML Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Table 18: CML Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Table 19: CML Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010*
Table 20: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2010*
Table 21: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010*
Table 22: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemGenex Pharmaceuticals Limited, 2010*
Table 23: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010*
Table 24: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Therapeutics Limited, 2010*
Table 25: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2010*
Table 26: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2010*
Table 27: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by SuperGen, Inc., 2010*
Table 28: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Natco Pharma Limited, 2010*
Table 29: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Athersys, Inc., 2010*
Table 30: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Path Holdings, Inc., 2010*
Table 31: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by akeda Pharmaceutical Company Limited, 2010*
Table 32: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Erimos Pharmaceuticals, LLC, 2010*
Table 33: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2010*
Table 34: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunesis Pharmaceuticals, Inc., 2010*
Table 35: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiron Corporation, 2010*
Table 36: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010*
Table 37: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010*
Table 38: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-TechnologyTransfer, 2010*
Table 39: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2010*
Table 40: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2010*
Table 41: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2010*
Table 42: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2010*
Table 43: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010*
Table 44: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bologna, 2010*
Table 45: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010*
Table 46: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by IU Simon Cancer Center, 2010*
Table 47: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2010*
Table 48: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Howard Gurney, 2010*
Table 49: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland Marlene and Stewart Greenebaum Cancer Center, 2010*
Table 50: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2010*
Table 51: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2010*
Table 52: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale Cancer Center, 2010*
Table 53: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2010*
Table 54: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by HOVON, 2010*
Table 55: CML Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2010*

List of Chart


Figure 1: CML Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 8
Figure 2: CML Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 9
Figure 3: CML Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010* 10
Figure 4: CML Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 11
Figure 5: CML Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 12
Figure 6: CML Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 13
Figure 7: CML Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2010* 14
Figure 8: CML Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010* 15
Figure 9: CML Therapeutics Clinical Trials, BRIC Countries (%), 2010* 16
Figure 10: CML Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 17
Figure 11: CML Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 18
Figure 12: CML Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 19
Figure 13: CML Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 23
Figure 14: CML Therapeutics Clinical Trials, Global, Enrollment Target Trends by Phase and Year, 2001-2010* 24
Figure 15: CML Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 25
Figure 16: CML Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 26
Figure 17: CML Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 2010* 28
Figure 18: GlobalData Methodology 55

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *